down arrow

Eastwood Bio-Medical Canada, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA27783W1059
CAD
1.00
0.00 (0.00%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.291.10
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 41 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

25.25%

stock-summary
Price to Book

-26.62

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Apr 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
132.56%
0%
132.56%
6 Months
150.0%
0%
150.0%
1 Year
33.33%
0%
33.33%
2 Years
53.85%
0%
53.85%
3 Years
-23.08%
0%
-23.08%
4 Years
-16.67%
0%
-16.67%
5 Years
-54.55%
0%
-54.55%

Eastwood Bio-Medical Canada, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.61%
EBIT Growth (5y)
6.50%
EBIT to Interest (avg)
-0.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
-0.72
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-19.30
EV to EBIT
-30.01
EV to EBITDA
-30.01
EV to Capital Employed
-19.97
EV to Sales
30.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is -50.00% vs 0.00% in Jan 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 0.00% vs 100.00% in Jan 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,026.30%",
          "val2": "-187.20%",
          "chgp": "-183.91%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Oct'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Oct 2024 is -22.22% vs -30.77% in Oct 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Oct 2024 is 0.00% vs -400.00% in Oct 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Oct'24",
        "Oct'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "0.90",
          "chgp": "-22.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.40",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.50",
          "val2": "-0.50",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-622.30%",
          "val2": "-583.00%",
          "chgp": "-3.93%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQstock-summary
Apr'25
Jan'25
Change(%)
Net Sales
0.10
0.20
-50.00%
Operating Profit (PBDIT) excl Other Income
-0.20
0.00
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.20
-0.00
Operating Profit Margin (Excl OI)
-2,026.30%
-187.20%
-183.91%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Apr 2025 is -50.00% vs 0.00% in Jan 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 0.00% vs 100.00% in Jan 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Oct'24stock-summary
Oct'24
Oct'23
Change(%)
Net Sales
0.70
0.90
-22.22%
Operating Profit (PBDIT) excl Other Income
-0.30
-0.40
25.00%
Interest
0.00
0.00
Exceptional Items
-0.00
0.00
Consolidate Net Profit
-0.50
-0.50
Operating Profit Margin (Excl OI)
-622.30%
-583.00%
-3.93%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Oct 2024 is -22.22% vs -30.77% in Oct 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Oct 2024 is 0.00% vs -400.00% in Oct 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Eastwood Bio-Medical Canada, Inc. stock-summary
stock-summary
Eastwood Bio-Medical Canada, Inc.
Pharmaceuticals & Biotechnology
Eastwood Bio-Medical Canada Inc. (EMBC) is a natural health supplement distribution company. The Company is engaged in the marketing and distributing natural health products in North America. It is a distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders, such as blood glucose disorders, hypertension and obesity. The Company's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.
Company Coordinates stock-summary
Company Details
1130-4871 Shell Rd , RICHMOND BC : V6X 3Z6
stock-summary
Tel: 1 604 2472100
stock-summary
https://eleotin.ca/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."